Search

everythinglearnresearchcommunity

for

Search:↓

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Melatonin improved mental health and metabolism in women with PCOS.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.